- Home
- CTXR vs NERV Comparison
CTXR vs NERV Comparison
Compare CTXR & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- NERV
- Stock Information
- Founded
- CTXR 2007
- NERV 2007
- Country
- CTXR United States
- NERV United States
- Employees
- CTXR N/A
- NERV N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- CTXR Health Care
- NERV Health Care
- Exchange
- CTXR Nasdaq
- NERV Nasdaq
- Market Cap
- CTXR 14.6M
- NERV 12.4M
- IPO Year
- CTXR N/A
- NERV 2014
- Fundamental
- Price
- CTXR $0.94
- NERV $1.54
- Analyst Decision
- CTXR Strong Buy
- NERV Hold
- Analyst Count
- CTXR 2
- NERV 1
- Target Price
- CTXR $54.50
- NERV $5.00
- AVG Volume (30 Days)
- CTXR 142.3K
- NERV 5.9K
- Earning Date
- CTXR 05-23-2025
- NERV 05-13-2025
- Dividend Yield
- CTXR N/A
- NERV N/A
- EPS Growth
- CTXR N/A
- NERV N/A
- EPS
- CTXR N/A
- NERV 0.82
- Revenue
- CTXR N/A
- NERV N/A
- Revenue This Year
- CTXR N/A
- NERV N/A
- Revenue Next Year
- CTXR N/A
- NERV N/A
- P/E Ratio
- CTXR N/A
- NERV $1.95
- Revenue Growth
- CTXR N/A
- NERV N/A
- 52 Week Low
- CTXR $0.68
- NERV $1.15
- 52 Week High
- CTXR $26.25
- NERV $3.69
- Technical
- Relative Strength Index (RSI)
- CTXR 51.36
- NERV 40.92
- Support Level
- CTXR $0.65
- NERV $1.58
- Resistance Level
- CTXR $0.82
- NERV $1.74
- Average True Range (ATR)
- CTXR 0.09
- NERV 0.08
- MACD
- CTXR 0.04
- NERV -0.01
- Stochastic Oscillator
- CTXR 85.69
- NERV 6.78
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.